TipRanks
Advertisement
Advertisement

DE:WEK0 Stock Latest News

Alaunos Therapeutics Faces Nasdaq Delisting, Seeks Hearing
Company AnnouncementsAlaunos Therapeutics Faces Nasdaq Delisting, Seeks Hearing
3d ago
8K
TCRT
Alaunos Therapeutics Announces New Registered Direct Offering
PremiumCompany Announcements
Alaunos Therapeutics Announces New Registered Direct Offering
20d ago
8K
TCRT
Alaunos Therapeutics prices 380,469 shares at $1.46 in registered direct offer
PremiumThe Fly
Alaunos Therapeutics prices 380,469 shares at $1.46 in registered direct offer
24d ago
TCRT
Alaunos Therapeutics Updates Bylaws to Ease Shareholder Quorum
PremiumCompany Announcements
Alaunos Therapeutics Updates Bylaws to Ease Shareholder Quorum
25d ago
8K
TCRT
Alaunos Reports New Preclinical Liver Data for ALN1003
PremiumCompany Announcements
Alaunos Reports New Preclinical Liver Data for ALN1003
4M ago
8K
TCRT
Alaunos Therapeutics reports metabolic improvements with ALN1003 in studies
PremiumThe FlyAlaunos Therapeutics reports metabolic improvements with ALN1003 in studies
5M ago
TCRT
Alaunos Reports Positive Preclinical Metabolic Data for ALN1003
Premium
Company Announcements
Alaunos Reports Positive Preclinical Metabolic Data for ALN1003
5M ago
8K
TCRT
Alaunos Highlights New Preclinical Data for Obesity Therapy
Premium
Company Announcements
Alaunos Highlights New Preclinical Data for Obesity Therapy
5M ago
8K
TCRT
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
PremiumThe Fly
Alaunos Therapeutics reports updated preclinical data from ALN1003 mouse studies
5M ago
TCRT
Valion Bio names Melinda Lackey as General Counsel
PremiumThe Fly
Valion Bio names Melinda Lackey as General Counsel
5M ago
TCRT
VBIO
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
PremiumCompany Announcements
Alaunos Therapeutics Faces Nasdaq Non-Compliance, Delisting Risk
6M ago
8K
TCRT
Alaunos Reports Positive Preclinical Data for Obesity Candidate
PremiumCompany Announcements
Alaunos Reports Positive Preclinical Data for Obesity Candidate
7M ago
8K
TCRT
Alaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
PremiumThe FlyAlaunos Therapeutics reports ‘positive’ proof-of-concept data for ALN1003
7M ago
TCRT
Alaunos Updates Governance, Ends Cantor Advisory Agreement
Premium
Company Announcements
Alaunos Updates Governance, Ends Cantor Advisory Agreement
9M ago
8K
TCRT
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
Premium
Company Announcements
Alaunos Therapeutics Reaches Settlement With MD Anderson Cancer
10M ago
8K
TCRT
Alaunos Therapeutics files to sell 327,740 shares of common for holders
PremiumThe Fly
Alaunos Therapeutics files to sell 327,740 shares of common for holders
12M ago
TCRT
Alaunos Therapeutics files $50M mixed securities shelf
PremiumThe Fly
Alaunos Therapeutics files $50M mixed securities shelf
1y ago
TCRT
Alaunos Therapeutics Regains Nasdaq Compliance
PremiumCompany Announcements
Alaunos Therapeutics Regains Nasdaq Compliance
1y ago
8K
TCRT
Alaunos Therapeutics Announces Departure of Melinda Lackey
PremiumCompany Announcements
Alaunos Therapeutics Announces Departure of Melinda Lackey
1y ago
8K
TCRT
Alaunos Therapeutics Holds Annual Stockholders Meeting
PremiumCompany AnnouncementsAlaunos Therapeutics Holds Annual Stockholders Meeting
1y ago
8K
TCRT
Alaunos Therapeutics Appoints Holger Weis as New CEO
Premium
Company Announcements
Alaunos Therapeutics Appoints Holger Weis as New CEO
1y ago
8K
TCRT
Alaunos Therapeutics Raises $850,000 in Private Offering
Premium
Company Announcements
Alaunos Therapeutics Raises $850,000 in Private Offering
1y ago
8K
TCRT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >